Literature DB >> 26443838

Extended RAS Gene Mutation Testing in Metastatic Colorectal Carcinoma to Predict Response to Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update 2015 Summary.

Carmen J Allegra1, R Bryan Rumble1, Richard L Schilsky1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26443838     DOI： 10.1200/JOP.2015.007898

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN： 1554-7477            Impact factor:   3.840


× No keyword cloud information.
  10 in total

Review 1.  Biologics in bowel cancer.

Authors:  Marcus S Noel
Journal:  J Gastrointest Oncol       Date:  2017-06

Review 2.  Colorectal cancer molecular profiling: from IHC to NGS in search of optimal algorithm.

Authors:  Larissa V Furtado; Wade S Samowitz
Journal:  Virchows Arch       Date:  2017-05-27       Impact factor: 4.064

3.  RAS screening in colorectal cancer: a comprehensive analysis of the results from the UK NEQAS colorectal cancer external quality assurance schemes (2009-2016).

Authors:  Susan D Richman; Jennifer Fairley; Rachel Butler; Zandra C Deans
Journal:  Virchows Arch       Date:  2017-06-26       Impact factor: 4.064

Review 4.  Incorporating BEAMing technology as a liquid biopsy into clinical practice for the management of colorectal cancer patients: an expert taskforce review.

Authors:  J García-Foncillas; E Alba; E Aranda; E Díaz-Rubio; R López-López; J Tabernero; A Vivancos
Journal:  Ann Oncol       Date:  2017-12-01       Impact factor: 32.976

5.  Comparison of the Clinical Sensitivity of the Idylla Platform and the OncoBEAM RAS CRC Assay for KRAS Mutation Detection in Liquid Biopsy Samples.

Authors:  Ana Vivancos; Enrique Aranda; Manuel Benavides; Elena Élez; Maria Auxiliadora Gómez-España; Marta Toledano; Martina Alvarez; Maria Rosario Chica Parrado; Vanesa García-Barberán; Eduardo Diaz-Rubio
Journal:  Sci Rep       Date:  2019-06-20       Impact factor: 4.379

6.  Effective management of advanced colon cancer genotyping microsatellite stable/microsatellite instable-low with Kirsten rat sarcoma viral oncogene mutation using nivolumab plus ipilimumab combined with regorafenib and irinotecan: A case report.

Authors:  Yingqiang Cui; Yimeng Ou; Yongping Luo; Jiongbiao Yu; Yiguang Lin; Size Chen
Journal:  SAGE Open Med Case Rep       Date:  2021-06-23

Review 7.  Molecular Diagnostics for Precision Medicine in Colorectal Cancer: Current Status and Future Perspective.

Authors:  Guoli Chen; Zhaohai Yang; James R Eshleman; George J Netto; Ming-Tseh Lin
Journal:  Biomed Res Int       Date:  2016-09-06       Impact factor: 3.411

8.  Clinical utility of circulating cell-free DNA in advanced colorectal cancer.

Authors:  Allan A Lima Pereira; Maria Pia Morelli; Michael Overman; Bryan Kee; David Fogelman; Eduardo Vilar; Imad Shureiqi; Kanwal Raghav; Cathy Eng; Shanequa Manuel; Shadarra Crosby; Robert A Wolff; Kimberly Banks; Richard Lanman; AmirAli Talasaz; Scott Kopetz; Van Morris
Journal:  PLoS One       Date:  2017-08-29       Impact factor: 3.240

9.  Genomic Profiling for KRAS, NRAS, BRAF, Microsatellite Instability, and Mismatch Repair Deficiency Among Patients With Metastatic Colon Cancer.

Authors:  Martin E Gutierrez; Kristin S Price; Richard B Lanman; Rebecca J Nagy; Irfan Shah; Shivam Mathura; Michael Mulcahy; Andrew D Norden; Stuart L Goldberg
Journal:  JCO Precis Oncol       Date:  2019-12-06

10.  Clinicopathological characteristics and mutational profile of KRAS and NRAS in Tunisian patients with sporadic colorectal cancer

Authors:  Donia Ounissi; Marwa Weslati; Rahma Boughriba; Meriam Hazgui; Saadia Bouraoui
Journal:  Turk J Med Sci       Date:  2021-02-26       Impact factor: 2.925
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.